Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures

Abstract Late Onset Alzheimer’s Disease is the most common cause of dementia, characterized by extracellular deposition of plaques primarily of amyloid-β (Aβ) peptide and tangles primarily of hyperphosphorylated tau protein. We present data to suggest a noninvasive strategy to decrease potentially t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Felipe P. Perez, Bryan Maloney, Nipun Chopra, Jorge J. Morisaki, Debomoy K. Lahiri
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7d0206775ab945e6a8c0d089921b69d3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7d0206775ab945e6a8c0d089921b69d3
record_format dspace
spelling oai:doaj.org-article:7d0206775ab945e6a8c0d089921b69d32021-12-02T15:23:07ZRepeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures10.1038/s41598-020-77808-22045-2322https://doaj.org/article/7d0206775ab945e6a8c0d089921b69d32021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-77808-2https://doaj.org/toc/2045-2322Abstract Late Onset Alzheimer’s Disease is the most common cause of dementia, characterized by extracellular deposition of plaques primarily of amyloid-β (Aβ) peptide and tangles primarily of hyperphosphorylated tau protein. We present data to suggest a noninvasive strategy to decrease potentially toxic Aβ levels, using repeated electromagnetic field stimulation (REMFS) in primary human brain (PHB) cultures. We examined effects of REMFS on Aβ levels (Aβ40 and Aβ42, that are 40 or 42 amino acid residues in length, respectively) in PHB cultures at different frequencies, powers, and specific absorption rates (SAR). PHB cultures at day in vitro 7 (DIV7) treated with 64 MHz, and 1 hour daily for 14 days (DIV 21) had significantly reduced levels of secreted Aβ40 (p = 001) and Aβ42 (p = 0.029) peptides, compared to untreated cultures. PHB cultures (DIV7) treated at 64 MHz, for 1 or 2 hour during 14 days also produced significantly lower Aβ levels. PHB cultures (DIV28) treated with 64 MHz 1 hour/day during 4 or 8 days produced a similar significant reduction in Aβ40 levels. 0.4 W/kg was the minimum SAR required to produce a biological effect. Exposure did not result in cellular toxicity nor significant changes in secreted Aβ precursor protein-α (sAPPα) levels, suggesting the decrease in Aβ did not likely result from redirection toward the α-secretase pathway. EMF frequency and power used in our work is utilized in human magnetic resonance imaging (MRI, thus suggesting REMFS can be further developed in clinical settings to modulate Aβ deposition.Felipe P. PerezBryan MaloneyNipun ChopraJorge J. MorisakiDebomoy K. LahiriNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Felipe P. Perez
Bryan Maloney
Nipun Chopra
Jorge J. Morisaki
Debomoy K. Lahiri
Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
description Abstract Late Onset Alzheimer’s Disease is the most common cause of dementia, characterized by extracellular deposition of plaques primarily of amyloid-β (Aβ) peptide and tangles primarily of hyperphosphorylated tau protein. We present data to suggest a noninvasive strategy to decrease potentially toxic Aβ levels, using repeated electromagnetic field stimulation (REMFS) in primary human brain (PHB) cultures. We examined effects of REMFS on Aβ levels (Aβ40 and Aβ42, that are 40 or 42 amino acid residues in length, respectively) in PHB cultures at different frequencies, powers, and specific absorption rates (SAR). PHB cultures at day in vitro 7 (DIV7) treated with 64 MHz, and 1 hour daily for 14 days (DIV 21) had significantly reduced levels of secreted Aβ40 (p = 001) and Aβ42 (p = 0.029) peptides, compared to untreated cultures. PHB cultures (DIV7) treated at 64 MHz, for 1 or 2 hour during 14 days also produced significantly lower Aβ levels. PHB cultures (DIV28) treated with 64 MHz 1 hour/day during 4 or 8 days produced a similar significant reduction in Aβ40 levels. 0.4 W/kg was the minimum SAR required to produce a biological effect. Exposure did not result in cellular toxicity nor significant changes in secreted Aβ precursor protein-α (sAPPα) levels, suggesting the decrease in Aβ did not likely result from redirection toward the α-secretase pathway. EMF frequency and power used in our work is utilized in human magnetic resonance imaging (MRI, thus suggesting REMFS can be further developed in clinical settings to modulate Aβ deposition.
format article
author Felipe P. Perez
Bryan Maloney
Nipun Chopra
Jorge J. Morisaki
Debomoy K. Lahiri
author_facet Felipe P. Perez
Bryan Maloney
Nipun Chopra
Jorge J. Morisaki
Debomoy K. Lahiri
author_sort Felipe P. Perez
title Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
title_short Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
title_full Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
title_fullStr Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
title_full_unstemmed Repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
title_sort repeated electromagnetic field stimulation lowers amyloid-β peptide levels in primary human mixed brain tissue cultures
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7d0206775ab945e6a8c0d089921b69d3
work_keys_str_mv AT felipepperez repeatedelectromagneticfieldstimulationlowersamyloidbpeptidelevelsinprimaryhumanmixedbraintissuecultures
AT bryanmaloney repeatedelectromagneticfieldstimulationlowersamyloidbpeptidelevelsinprimaryhumanmixedbraintissuecultures
AT nipunchopra repeatedelectromagneticfieldstimulationlowersamyloidbpeptidelevelsinprimaryhumanmixedbraintissuecultures
AT jorgejmorisaki repeatedelectromagneticfieldstimulationlowersamyloidbpeptidelevelsinprimaryhumanmixedbraintissuecultures
AT debomoyklahiri repeatedelectromagneticfieldstimulationlowersamyloidbpeptidelevelsinprimaryhumanmixedbraintissuecultures
_version_ 1718387333961613312